It has been announced that so-called “gender identity clinics” run by NHS England will no longer be permitted to prescribe the drugs known as “puberty blockers”.
Aninterim reportfrom within a wider review into gender identity services in England, which is due to be published in the next few weeks, raised concerns surrounding the purported safety of these drugs that halt the production of hormones such as oestrogen and testosterone in order to delay and “block” the effects of puberty for children diagnosed with gender dysphoria.
